Case Study: Almirall advances psoriasis innovation with Opinno's patient-centered PsOlve cycle

Almirall accelerates psoriasis innovation with Opinno’s 25-application open innovation cycle

Almirall, a global pharmaceutical company focused on medical dermatology, faced the challenge of improving the quality of life for patients with moderate-to-severe psoriasis beyond pharmacological treatment. To address this, they partnered with vendor Opinno to launch the PsOlve innovation cycle.

Opinno designed and managed the full international open innovation process, which included application screening and an innovation coaching program for finalists. The results included 25 applications from four countries, with five teams receiving seven hours of mentoring each. The measurable impact was a 100% recommendation rate for the mentoring, with two out of three teams significantly improving their initiatives. The winning project was an AI-powered tool for clinicians called PsOver.

Almirall